Literature DB >> 17194654

Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.

Antonio Ruggiero1, Palma Maurizi, Luigi Maria Larocca, Annalisa Arlotta, Riccardo Riccardi.   

Abstract

Recently, rare CD4+/CD56+ hematodermic neoplasm has been described as a distinct clinico-pathologic entity, with aggressive course and poor outcome. Skin is typically involved at presentation, but widespread dissemination to bone marrow is rapid. To date, no standardized therapeutic approach to this disease has been established. As its diffusion mainly concerns elderly patients, only a few paediatric cases have been documented. We report an additional case of CD4+/CD56+ hematodermic tumour that showed a good response to chemotherapy based on a lymphoma protocol. Moreover, we try to analyse features and outcome of a few other paediatric CD4+/CD56+ hematodermic tumours as they are reported in the literature.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17194654

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  8 in total

1.  Central nervous system involvement in CD4+/CD56+ hematodermic neoplasm: a report of two cases.

Authors:  Nóra Eros; Márta Marschalkó; Katalin Balassa; Bernadett Hídvégi; József Szakonyi; Sándor Ilniczky; Katalin Borka; Attila Kovács; Gyula Bottlik; Judit Hársing; Judit Csomor; Agota Szepesi; András Matolcsy; Sarolta Kárpáti; Judit Demeter
Journal:  J Neurooncol       Date:  2009-10-02       Impact factor: 4.130

Review 2.  Renal toxicity and chemotherapy in children with cancer.

Authors:  Antonio Ruggiero; Pietro Ferrara; Giorgio Attinà; Daniela Rizzo; Riccardo Riccardi
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

3.  Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia.

Authors:  Karen D Wright; Mihaela M Onciu; Elaine Coustan-Smith; Dario Campana; Susana C Raimondi; Hiroto Inaba; Raul Ribeiro; Ching-Hon Pui; John T Sandlund
Journal:  Pediatr Blood Cancer       Date:  2013-02-15       Impact factor: 3.167

4.  Blastic plasmacytoid dendritic cell neoplasm presenting as a subcutaneous mass in an 8-year-old boy.

Authors:  David Nizza; Stephen F Simoneaux
Journal:  Pediatr Radiol       Date:  2010-06-16

5.  Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.

Authors:  Armin G Jegalian; Nataliya P Buxbaum; Fabio Facchetti; Mark Raffeld; Stefania Pittaluga; Alan S Wayne; Elaine S Jaffe
Journal:  Haematologica       Date:  2010-07-27       Impact factor: 9.941

Review 6.  Blastic Plasmacytoid Dendritic Cell Neoplasm in the Pediatric Population: A Case Series and Review of the Literature.

Authors:  Catherine M Nguyen; Lauren Stuart; Hadas Skupsky; Yun-Sun Lee; Arline Tsuchiya; David S Cassarino
Journal:  Am J Dermatopathol       Date:  2015-12       Impact factor: 1.533

7.  Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment.

Authors:  Antonio Ruggiero; Daniela Rizzo; Martina Catalano; Paola Coccia; Silvia Triarico; Giorgio Attiná
Journal:  J Int Med Res       Date:  2018-04-24       Impact factor: 1.671

Review 8.  Temozolomide and oral etoposide in children with recurrent malignant brain tumors.

Authors:  Antonio Ruggiero; Anna Ariano; Silvia Triarico; Michele Antonio Capozza; Alberto Romano; Palma Maurizi; Stefano Mastrangelo; Giorgio Attinà
Journal:  Drugs Context       Date:  2020-06-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.